Skip to main content
Log in

The first international urokinase/warfarin trial in colorectal cancer

  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Abstract

Three hundred and forty-four patients with operable colorectal adenocarcinoma, Dukes' stage B or C, were entered into a randomized controlled trial of intraoperative and postoperative intravenous urokinase and/or long-term sodium warfarin therapy. The factorial design of the trial allowed evaluation of each therapy separaetely. Age, sex, Dukes' stage and cancer site were similar in the treatment groups. Using life-table methods, survival and recurrence/metastases free survival were estimated up to 6 years postoperatively. No significant effects of either therapy on these endpoints were found.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Clery, A. P., Hogan, B. L., Holland, P. D. J., Widdess, J. D. H., Ryan, M., Doyle, J. S., 1972, Early experience in a controlled clinical trial using streptokinase induced fibrinolysus during resections for colon and rectal carcinomas in an attempt to prevent haematogenous metastasis.Journal of the Irish College of Physicians and Surgeons,1, 91–95.

    Google Scholar 

  2. Cox, D. R., 1972, Regression models and life-tables (with discussion).Journal of the Royal Statistical Association, B34, 187–220.

    Google Scholar 

  3. George, S. L., andDesu, M. M., 1974, Planning the size and duration of a clinical trial studying the time to some critical event.Journal of Chronic Diseases,27, 15–24.

    PubMed  Google Scholar 

  4. Hilgard, P., andThornes, R. D., 1976, Anticoagulants in the treatment of cancer.European Journal of Cancer,12, 755–762.

    Google Scholar 

  5. Kaplan, E. L., andMeier, P., 1958, Nonparametric estimation from incomplete observations.Journal of the American Statistical Association,53, 457–481.

    Google Scholar 

  6. Kohanna, F. H., Sweeney, J., Hussey, S., Zacharski, L. R., andSalzman, E. W., 1983, Effect of perioperative low-dose heparin administration on the course of colon cancer.Surgery,93, 433–438.

    PubMed  Google Scholar 

  7. Maat, B., 1980, Selective macrophage inhibition abolishes warfarin-induced reduction of metastases.British Journal of Cancer,41, 313–316.

    PubMed  Google Scholar 

  8. Pasternack, B. S., andGilbert, H. S., 1971, Planning the duration of long-term survival time studies designed for accrual by cohorts.Journal of Chronic Diseases,24, 681–700.

    PubMed  Google Scholar 

  9. Peto, R., Pike, M. C., Armitage, P., Brelson, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Pete, J., andSmith, P. G., 1977, Design and analysis of randomized clinical trials requiring prolonged observation of each patient II Analysis and examples.British Journal of Cancer,35, 1–39.

    PubMed  Google Scholar 

  10. Salsbury, A. J., 1975, The significance of the circulating cancer cell.Cancer Treatment Reviews,2, 55–72.

    PubMed  Google Scholar 

  11. Thornes, R. D., 1967, Fibrinogen and the interstitial behaviour of cancer.Endogenous Factors Influencing Host-Tumour Balance, edited by R. W. Wissler, T. L. Dao and S. Wood Jr. (Chicago and London: University of Chicago Press), pp. 255–266.

    Google Scholar 

  12. Thornes, D., Daly, L., Lynch, G., Thornes, D., Daly, L., Lynch, G., Browne, H., Tanner, A., Keane, F., O'Loughlin, S., Corrigan, T., Daly, P., Edwards, G., Breslin, B., Browne, Hy., Shine, M., Lennon, F., Hanley, J., McMurray, N., andGaffney, E., 1989, prevention of early recurrence of high risk malignant melanoma by coumarin.European Journal of Surgical Oncology,15, 431–435.

    PubMed  Google Scholar 

  13. Törngren, S., andRieger, A., 1983, The influence of heparin and curable resection on the survival of colorectal cancer.Acta Chirurgica Scandinavica,149, 427–429.

    PubMed  Google Scholar 

  14. White, H., andGriffiths, J. D., 1976, Circulating malignant cells and fibrinolysis during resection of colorectal cancer.Proceedings of the Royal Society for Medicine,69, 467–469.

    Google Scholar 

  15. Wood, S. Jr, Holyoke, E. D., andYardley, J. H., 1961, Mechanisms of metastasis production from blood-borne cancer cells.Canadian Cancer Conference,4, 167–223.

    Google Scholar 

  16. Wojtukiewicz, M. Z., Zacharski, L. R., Memoli, V. A., Kisiel, W., Kudryk, B. J., Rousseau, S. M., andStump, D. C., 1989, Indirect activation of blood coagulation in colon cancer.Thrombosis and Haemostasis,62, 1062–1066.

    PubMed  Google Scholar 

  17. Zacharski, L. R., Henderson, W. G., Rickless, F. R., Forman, W. B., Cornell, C. J., Forcier, R. J., Edwards, R. L., Headley, E., Kim, S. H., O'Donnell, J. F., O'Dell, R., Tornyds, K., andKwaan, H. C., 1984, Effect of Warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate: final report of VA cooperative Study.Cancer,53, 2046–2052.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Daly, L. The first international urokinase/warfarin trial in colorectal cancer. Clin Exp Metast 9, 3–11 (1991). https://doi.org/10.1007/BF01831705

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01831705

Keywords

Navigation